What is an Endovascular Aneurysm Repair (EVAR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Endovascular Aneurysm Repair (EVAR)?

EVAR is a minimally invasive procedure that treats abdominal aortic aneurysms by placing a stent-graft inside the aneurysm to exclude it from arterial circulation, thereby preventing rupture. 1, 2

Procedure Overview

EVAR involves deploying a bifurcated or tubular stent-graft through small groin incisions (rather than open laparotomy) to line the inside of the aneurysm and redirect blood flow away from the weakened aortic wall. 2, 3 The stent-graft is typically inserted via the femoral arteries and positioned to create proximal and distal "landing zones" that seal against healthy aortic tissue. 1

Key Anatomic Requirements

For conventional EVAR to be feasible, specific anatomic criteria must be met:

  • Proximal neck length: ≥10-15 mm of healthy aorta below the renal arteries 1
  • Proximal neck diameter: <30 mm 1
  • Neck angulation and morphology: Favorable configuration without excessive calcification (>90% circumferential calcification increases risk of type I endoleak and graft migration) 1
  • Iliac access: Adequate diameter and tortuosity to accommodate device delivery 1

More than 50% of patients have anatomy unsuitable for conventional EVAR, though fenestrated EVAR (FEVAR) extends treatment options for those with inadequate neck length. 1

Clinical Advantages Over Open Repair

EVAR demonstrates significant perioperative benefits:

  • Reduced 30-day mortality: 1.7% with EVAR versus 4.7% with open repair (odds ratio 0.35, p=0.009) 1, 4
  • Decreased hospital stay and perioperative morbidity 1
  • Minimal surgical trauma: Only requires stab incisions rather than laparotomy 2, 5
  • Faster recovery time 2, 3

However, long-term mortality equivalence emerges over time, with similar all-cause mortality rates at 6 years (7.5 vs 7.7 deaths per 100 person-years, p=0.72). 1

Critical Limitation: Lifelong Surveillance Requirement

The primary trade-off of EVAR is mandatory lifelong imaging surveillance due to higher reintervention rates compared to open repair (5.1% vs 1.7%, p=0.001). 1 This surveillance requirement makes EVAR less suitable for patients unable to comply with regular follow-up. 1, 3

Surveillance Must Monitor For:

  • Endoleaks (most common complication—blood flow outside graft but inside aneurysm sac) 1
  • Aneurysm sac expansion (indicating treatment failure and rupture risk) 1
  • Stent-graft complications: Migration, kinking, thrombosis, infection 1
  • Renal dysfunction 1

Endoleak Classification and Management

Endoleaks occur in up to one-third of EVAR cases and are classified by etiology: 1

  • Type I and Type III: Require immediate correction as they expose the sac to systemic pressure 1
  • Type II: Present in ~25% of patients but may spontaneously seal 1

Current Guideline Recommendations

For patients with suitable anatomy and reasonable life expectancy (>2 years), EVAR should be considered as the preferred therapy based on shared decision-making. 1 The 2024 ESC guidelines specifically recommend EVAR over open repair for ruptured AAA with suitable anatomy to reduce perioperative morbidity and mortality. 1

Open repair remains reasonable for good surgical candidates who cannot comply with lifelong surveillance requirements. 1

Common Pitfall to Avoid

Do not offer EVAR to patients with limited life expectancy (<2 years) or those unlikely to maintain long-term imaging follow-up, as the reintervention burden negates perioperative advantages. 1 The requirement for lifelong CTA surveillance (with associated radiation exposure and contrast nephrotoxicity risk) must be explicitly discussed during shared decision-making. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.